Non-response to first-line anti-tuberculosis treatment in Sikkim, India: a risk-factor analysis study.

Sikkim, India, has the highest proportion of tuberculosis (TB) patients on first-line anti-tuberculosis regimens with the outcome 'failure' or 'shifted to regimen for multidrug-resistant TB (MDR-TB)'. To assess the factors associated with non-response to treatment, i.e.